News

Pharmabiz4h
Phanes Therapeutics begins patient dosing in clinical study of mavrostobart in combination with chemotherapy
Phanes Therapeutics begins patient dosing in clinical study of mavrostobart in combination with chemotherapy: San Diego Wednesday, May 28, 2025, 18:00 Hrs [IST] Phanes Therapeutic ...
Pharmabiz5h
Granules reports Q4FY25 revenue from operations at Rs. 1,197.4 crore up by 2% YoY
Granules reports Q4FY25 revenue from operations at Rs. 1,197.4 crore up by 2% YoY: Our Bureau, Bengaluru Wednesday, May 28, 2025, 17:15 Hrs [IST] Granules India Ltd., a vertically ...
Pharmabiz5h
US FDA approves Bio-Thera Solutions & Hikma Pharma’s Starjemza injection, a biosimilar referencing Stelara injection
US FDA approves Bio-Thera Solutions & Hikma Pharma’s Starjemza injection, a biosimilar referencing Stelara injection: Guangzhou Wednesday, May 28, 2025, 17:00 Hrs [IST] Bio-Ther ...
Pharmabiz5h
USV’s ‘United for BP Control’ mission targets India’s blood pressure epidemic
USV’s ‘United for BP Control’ mission targets India’s blood pressure epidemic: Our Bureau, Bengaluru Wednesday, May 28, 2025, 17:30 Hrs [IST] USV has launched the ‘Unite ...
Pharmabiz6h
Multi-institutional study highlights role of robotic-assisted surgery in reshaping gynaecological care in India
Multi-institutional study highlights role of robotic-assisted surgery in reshaping gynaecological care in India: Our Bureau, Bengaluru Wednesday, May 28, 2025, 16:15 Hrs [IST] As ...
Pharmabiz6h
Faron Pharma’s bexmarilimab demonstrates immune-activating and drug-sensitizing potential in myeloid malignancies
Faron Pharma’s bexmarilimab demonstrates immune-activating and drug-sensitizing potential in myeloid malignancies: Turku, Finland Wednesday, May 28, 2025, 16:00 Hrs [IST] Faron ...
Pharmabiz6h
Sir H N Reliance Foundation Hospital launches advanced lung disease clinic to fight pulmonary disorders
Sir H N Reliance Foundation Hospital launches advanced lung disease clinic to fight pulmonary disorders: Our Bureau, Mumbai Wednesday, May 28, 2025, 16:30 Hrs [IST] In a significa ...
Pharmabiz7h
GRIN Therapeutics & Angelini Pharma ink exclusive collaboration to develop and commercialize radiprodil outside North America
GRIN Therapeutics & Angelini Pharma ink exclusive collaboration to develop and commercialize radiprodil outside North America: New York Wednesday, May 28, 2025, 15:00 Hrs [IST] GR ...
Pharmabiz8h
Rohini Nilekani Philanthropies, Dalberg Advisors and Ashoka Changemakers present study on ageing and longevity in India
Rohini Nilekani Philanthropies, Dalberg Advisors and Ashoka Changemakers present study on ageing and longevity in India: Our Bureau, Bengaluru Wednesday, May 28, 2025, 13:50 Hrs [ ...
Pharmabiz13h
Sanofi completes acquisition of DR-0201, a bispecific myeloid cell engager from Dren Bio
Sanofi completes acquisition of DR-0201, a bispecific myeloid cell engager from Dren Bio: Paris Wednesday, May 28, 2025, 09:00 Hrs [IST] Sanofi announces the completion of its acq ...
Pharmabiz8h
US FDA places clinical hold on Rocket Pharma's gene therapy phase 2 trial of RP-A501 to treat Danon disease
US FDA places clinical hold on Rocket Pharma's gene therapy phase 2 trial of RP-A501 to treat Danon disease: Cranbury, New Jersey Wednesday, May 28, 2025, 14:00 Hrs [IST] Rocket P ...
Pharmabiz10h
Rein Therapeutics begins patient dosing in in RENEW phase 2 trial of LTI-03 to treat idiopathic pulmonary fibrosis
Rein Therapeutics begins patient dosing in in RENEW phase 2 trial of LTI-03 to treat idiopathic pulmonary fibrosis: Austin, Texas Wednesday, May 28, 2025, 12:00 Hrs [IST] Rein The ...